Arkolith/Insider Trading/KNSA/Form 4

Patel Sanj K

CHAIRMAN & CEO, DirectorKiniksa Pharmaceuticals International, plc (KNSA) · full profile →Form 4 · filed Nov 14, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 13, 2025Gift(G)60K—$052K
Nov 13, 2025Gift(G)60K—$060K
Nov 12, 2025Gift(G)112K—$0112K
Nov 12, 2025Gift(G)112K—$00

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001532218-25-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML